PD-L1 expression in penile cancer: a new frontier for immune checkpoint inhibitors?

被引：5
|
作者：
Al-Ahmadie, H. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷 / 09期
关键词：
NIVOLUMAB; IPILIMUMAB; CARCINOMA; PEMBROLIZUMAB; OPPORTUNITIES; BLADDER; CELLS;
D O I：
10.1093/annonc/mdw268
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1658 / 1659
页数：2
相关论文
共 50 条
  • [21] Patients' sex and PD-L1 expression jointly associated with overall survival benefits of immune checkpoint inhibitors in cancer
    Yu, Y.
    Li, A.
    Chen, Y.
    Zhang, W.
    Zhong, H.
    Gu, Y.
    Ou, Q.
    Xia, J.
    Lin, D.
    Fu, T.
    Li, L.
    Liu, R.
    Yao, H.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S713 - S713
  • [22] Estimate of Economic Impact of Immune Checkpoint Inhibitors for NSCLC Relative to PD-L1 Expression in the US
    Aguiar, Pedro, Jr.
    De Mello, Ramon
    Tadokoro, Hakaru
    Babiker, Hani
    Gutierres, Barbara
    Lopes, Gilberto
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S308 - S308
  • [23] The immune checkpoint regulator PD-L1 expression are associated with clinical progression in prostate cancer
    He, Juan
    Yi, Min
    Tan, Lingfeng
    Huang, Jianghua
    Huang, Lin
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [24] The immune checkpoint regulator PD-L1 expression are associated with clinical progression in prostate cancer
    Juan He
    Min Yi
    Lingfeng Tan
    Jianghua Huang
    Lin Huang
    [J]. World Journal of Surgical Oncology, 19
  • [25] Effect of Platelets and their Pharmacological Regulation on Cancer Cell Immune Checkpoint PD-L1 Expression
    Lesyk, Gabriela Maria
    Poitras, Erika
    Jurasz, Paul
    [J]. FASEB JOURNAL, 2018, 32 (01):
  • [26] Expression patterns of PD-L1 and other immune checkpoint molecules in gastric cancer.
    Nakamura, Kenichi
    Hatakeyama, Keiichi
    Toriumi, Tetsuro
    Koseki, Yusuke
    Waki, Yuhei
    Fujiya, Keiichi
    Kamiya, Satoshi
    Makuuchi, Rie
    Tanizawa, Yutaka
    Bando, Etsuro
    Kawamura, Taiichi
    Yamaguchi, Ken
    Terashima, Masanori
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [27] The Roles of microRNAs in Regulating the Expression of PD-1/PD-L1 Immune Checkpoint
    Wang, Qingshui
    Lin, Wei
    Tang, Xiaoqiong
    Li, Suhuan
    Guo, Libin
    Lin, Yao
    Kwok, Hang Fai
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (12)
  • [28] Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies
    Dongxu Wang
    Jianzhen Lin
    Xu Yang
    Junyu Long
    Yi Bai
    Xiaobo Yang
    Yilei Mao
    Xinting Sang
    Samuel Seery
    Haitao Zhao
    [J]. Journal of Hematology & Oncology, 12
  • [29] Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies
    Wang, Dongxu
    Lin, Jianzhen
    Yang, Xu
    Long, Junyu
    Bai, Yi
    Yang, Xiaobo
    Mao, Yilei
    Sang, Xinting
    Seery, Samuel
    Zhao, Haitao
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
  • [30] The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma
    Mahoney, Kathleen M.
    Freeman, Gordon J.
    McDermott, David F.
    [J]. CLINICAL THERAPEUTICS, 2015, 37 (04) : 764 - 782
12345